MedPath

V-C15 - LIQ

V-C15 - LIQ

Discontinued
DIN Number

02120526

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

dr reckeweg canada

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02120526
AIG Number0626548001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (6)

COCCULUS INDICUSActive
Strength: 5 D / ML
Monograph: COCCULUS INDICUS
HELONIASActive
Strength: 5 D / ML
Monograph: HELONIAS
LEMONActive
Strength: 1 D / ML
Monograph: LEMON
PHOSPHORIC ACIDActive
Strength: 3 D / ML
Monograph: PHOSPHORIC ACID
SEPIA OFFICINALIS LActive
Strength: 6 D / ML
Monograph: SEPIA OFFICINALIS L
ZINCActive
Strength: 6 D / ML
Monograph: ZINC

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.